Special Issue "Drug and Gene Delivery Strategies for Breast Cancer Therapy"
Deadline for manuscript submissions: 15 January 2024 | Viewed by 3296
Interests: siRNA; RNAi; nanoparticles; nanocarriers; qPCR; molecular biology
Special Issues, Collections and Topics in MDPI journals
Breast cancers still pose major challenges to health sciences. They are complex diseases that affect women worldwide. At present, the therapies available for the treatment of breast cancer have a wide range of side effects and systemic complications, reducing the well-being of the patient and hindering their recovery. Moreover, tumor resistance to chemotherapeutics, tumor recurrence and metastasis are huge obstacles to be overcome to reach an improved prognosis. Thus, new therapeutic strategies for more effective treatments are urgently required.
Novel drug and gene delivery systems may have the ability to overcome the hurdles and ultimately improve the prognosis. Nano-sized medicines containing either nucleic acids or chemical drugs that act by reducing proliferation, survival, differentiation, invasion, and angiogenesis are promising systems. In addition, these systems can modulate pharmacokinetics and biodistribution, in order to concentrate the drug in specific tissues or modify the tumor microenvironment.
This Special Issue welcomes research pertaining to the design, development and application of novel drug and gene delivery systems for breast cancer therapy. Distinct strategies, such as the co-delivery of drugs or genes, siRNA-based systems, pDNA delivery systems, and CRISPR approaches, are especially welcome.
Prof. Dr. Frederico Pittella
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery system
- gene delivery
- breast cancer
- gene therapy